Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Barilar

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|August 30, 2021
Role of Epistasis in Amikacin, Kanamycin, Bedaquiline, and Clofazimine Resistance in Mycobacterium tuberculosis ComplexRoger Vargas, Luca Freschi, Andrea Spitaleri, et al.
Plos Computational Biology|December 5, 2022
Using genetic data to identify transmission risk factors: Statistical assessment and application to tuberculosis transmissionIsaac H Goldstein, Damon Bayer, Ivan Barilar, et al.
Microbiology Spectrum|January 30, 2024
Molecular determinants of multidrug-resistant tuberculosis in Sierra LeoneHarriet N A Blankson, Rashidatu Fouad Kamara, Ivan Barilar, et al.
Microbiology Spectrum|September 22, 2023
<i>In vitro</i> activity of new combinations of β-lactam and β-lactamase inhibitors against the <i>Mycobacterium tuberculosis</i> complexElin Economou Lundeberg, Viktoria Andersson, Maria Wijkander, et al.
The European Respiratory Journal|September 10, 2021
Emergence of bedaquiline resistance in a high tuberculosis burden countryElena Chesov, Dumitru Chesov, Florian P Maurer, et al.
Genome Medicine|August 21, 2022
High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan RegionViola Dreyer, Ayan Mandal, Prachi Dev, et al.
The Lancet. Infectious Diseases|November 13, 2023
Emergence of bedaquiline-resistant tuberculosis and of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains with rpoB Ile491Phe mutation not detected by Xpert MTB/RIF in Mozambique: a retrospective observational studyIvan Barilar, Tatiana Fernando, Christian Utpatel, et al.
Thorax|January 29, 2024
Challenging the gold standard: the limitations of molecular assays for detection of <i>Mycobacterium tuberculosis</i> heteroresistanceSarah N Danchuk, Ori E Solomon, Thomas Andreas Kohl, et al.
Emerging Infectious Diseases|February 25, 2020
Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Beijing Clades, Ukraine, 2015Matthias Merker, Elena Nikolaevskaya, Thomas A Kohl, et al.
Medrxiv : the Preprint Server for Health Sciences|January 7, 2025
Phylodynamic analysis reveals disparate transmission dynamics of <i>Mycobacterium tuberculosis</i>-complex lineages in BotswanaQiao Wang, Ivan Barilar, Volodymyr M Minin, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|August 30, 2021
Role of Epistasis in Amikacin, Kanamycin, Bedaquiline, and Clofazimine Resistance in Mycobacterium tuberculosis ComplexRoger Vargas, Luca Freschi, Andrea Spitaleri, et al.
Plos Computational Biology|December 5, 2022
Using genetic data to identify transmission risk factors: Statistical assessment and application to tuberculosis transmissionIsaac H Goldstein, Damon Bayer, Ivan Barilar, et al.
Microbiology Spectrum|January 30, 2024
Molecular determinants of multidrug-resistant tuberculosis in Sierra LeoneHarriet N A Blankson, Rashidatu Fouad Kamara, Ivan Barilar, et al.
Microbiology Spectrum|September 22, 2023
<i>In vitro</i> activity of new combinations of β-lactam and β-lactamase inhibitors against the <i>Mycobacterium tuberculosis</i> complexElin Economou Lundeberg, Viktoria Andersson, Maria Wijkander, et al.
The European Respiratory Journal|September 10, 2021
Emergence of bedaquiline resistance in a high tuberculosis burden countryElena Chesov, Dumitru Chesov, Florian P Maurer, et al.
Genome Medicine|August 21, 2022
High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan RegionViola Dreyer, Ayan Mandal, Prachi Dev, et al.
The Lancet. Infectious Diseases|November 13, 2023
Emergence of bedaquiline-resistant tuberculosis and of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains with rpoB Ile491Phe mutation not detected by Xpert MTB/RIF in Mozambique: a retrospective observational studyIvan Barilar, Tatiana Fernando, Christian Utpatel, et al.
Thorax|January 29, 2024
Challenging the gold standard: the limitations of molecular assays for detection of <i>Mycobacterium tuberculosis</i> heteroresistanceSarah N Danchuk, Ori E Solomon, Thomas Andreas Kohl, et al.
Emerging Infectious Diseases|February 25, 2020
Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Beijing Clades, Ukraine, 2015Matthias Merker, Elena Nikolaevskaya, Thomas A Kohl, et al.
Medrxiv : the Preprint Server for Health Sciences|January 7, 2025
Phylodynamic analysis reveals disparate transmission dynamics of <i>Mycobacterium tuberculosis</i>-complex lineages in BotswanaQiao Wang, Ivan Barilar, Volodymyr M Minin, et al.
Pageof 4